blog
AVMA voices veterinary needs to FDA about cannabis products
The U.S. Food and Drug Administration (FDA) should provide regulatory clarity about expectations for the labeling, safety, and use of cannabis-derived…
blog
Farm bill delivers victory for veterinary medicine
The nation’s new farm bill creates critical programs to improve animal health and enhance the nation’s ability to prevent and respond to animal…
blog
Law improves veterinary access to FDA-approved drugs
Veterinarians received good news from Washington recently: lawmakers passed the Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (H.R.…
blog
AVMA working group helps navigate opioid abuse epidemic
An AVMA working group has taken up the task of providing needed information to help veterinary professionals contribute productively to the national…
blog
DEA provides update on opioid shortage
The U.S. Drug Enforcement Administration (DEA) released a statement last week on the ongoing opioid shortages affecting both human and veterinary…
blog
What do the election results mean for veterinarians?
Last night, Democrats took control of the U.S. House of Representatives, and Republicans maintained control of the U.S. Senate. As with any change of…
blog
Get answers: Frequently asked questions about COVID-19
We’ve added two new resources to our COVID-19 webpage: FAQs for veterinarians and veterinary clinics, and for pet owners.
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
blog
AVMA Board meets with USDA official
AVMA’s Board of Directors met with the U.S. Department of Agriculture (USDA) under secretary for marketing and regulatory programs during last…
blog
Prescription mandates: new bill, same problems
For several consecutive congressional sessions, the AVMA has led the charge to defeat legislation that would require veterinarians to provide written…
blog
The VCPR: Why it needs to be established in person
The AVMA opposes a VCPR being established virtually because it creates serious risks for patient health and safety. Simply put, establishing the VCPR…
blog
Policies up for review: Your input needed
AVMA policy is powered by AVMA members. The review process for eight policies is starting, and the volunteer groups that conduct the review are…
blog
Speaking up and making our voice heard
President’s Column: Dr. John de Jong Last month, I shared with you my commitment to advocate on behalf of the veterinary profession by engaging with…
blog
Report identifies antimicrobial-resistant pathogens impacting animal health
A new report on antimicrobial-resistant pathogens and their impact on animal health is now available for AVMA members to download.
blog
Online sales tax awaits Supreme Court decision
The United States Supreme Court has heard arguments and is considering its decision in an online sales tax case in which the AVMA has urged it to…
blog
Antimicrobial resistance: Slowing and limiting its emergence and spread
As a practice owner, I have been struck by the number of antimicrobial-resistant bacterial infections my team and I have seen in our patients.
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
Here’s one promising approach to address rural veterinary shortages
There are veterinarians who want to work in rural areas of America but are unable to do so—for financial reasons. The great news is that legislation…